Adrenal suppression from exogenous glucocorticoids: Recognizing risk factors and preventing morbidity

Abstract Adrenal suppression (AS), a potential side effect of glucocorticoid therapy (including inhaled corticosteroids), can be associated with significant morbidity and even death. In Canada, adrenal crisis secondary to AS continues to be reported in children. Being aware of symptoms associated with AS, understanding the risk factors for developing this condition, and familiarity with potential strategies to reduce risks associated with AS, are essential starting points for any clinician prescribing glucocorticoids.

Adrenal suppression from exogenous glucocorticoids: Recognizing risk factors and preventing morbidity Journal Articles